Published by
Lin Wang, tianxu liu Hepatitis E, an infectious disease caused by hepatitis E virus (HEV) infection is currently the major acute viral hepatitis problem worldwide. Immunocompromised individuals, such as organ transplant r...
Published by
Morgan Herod Hepatitis E virus (HEV) is a leading cause of virally induced hepatitis (liver inflammation). Worldwide the WHO estimate that there are more than 20 million HEV infections each year. Healthy individua...
Published by
Morgan Herod Hepatitis E virus (HEV) is a common cause of acute viral hepatitis (inflammation of the liver). Although the infection usually self-resolves in healthy people, occasionally it can lead to acute liver ...
Published by
Qiuwei Abdullah Pan HEV infection caused liver diseases are closely related to dysregulation of immune responses, especially inflammatory response. Macrophages play a central role in immunosurveillance of the healthy liv...
Published by
Hassan Mahsoub, Xiang-Jin Meng Hepatitis E virus (HEV) causes adverse clinical outcomes in pregnant women, including preterm delivery, miscarriage, stillbirth, fulminant hepatic failure (FHF), and mortality. The underlying mechanis...
Published by
Eike Steinmann Although hepatitis E virus (HEV) is the most common cause for acute viral hepatitis with more than 20 million cases per year and 70 000 deaths annually, very little is known about the life cycle of ...
Published by
Debin Tian, Xiang-Jin Meng HEV infection is associated with nerve root and plexus sequelae, such as Guillain-Barré syndrome and neuralgic amyotrophy, in a significant proportion of HEV-infected individuals worldwide. Additiona...
Published by
Harini Sooryanarain, Xiang-Jin Meng Hepatitis E virus (HEV) infection is usually a self-limiting disease with an overall case-fatality rate of less than 1%; however in pregnant women mortality rate can increase up to 20-30%. The exact m...
Published by
Qiuwei Abdullah Pan, Yang Li HEV infection caused liver diseases are closely related to dysregulation of immune responses, especially inflammatory response. Macrophages play a central role in immunosurveillance of the healthy liv...
Published by
, Qiuwei Abdullah Pan, Pengfei Li Studying the biology of hepatitis E virus (HEV) infection and developing new therapeutics require robust experimental models. Although human liver cancer cell lines have been widely used to model HEV ...
GHEP offers free membership for your better connection with the hepatitis E community
EVENTS
2023-04-28
2nd International HEV Symposium The meeting will be held from April 28 to 29, 2023, in London. The 2-day meeting will feature talks and presentations given on the latest updates on HEV epidemiology, diagnostics, treatment, laboratory research, and disease control.
More information: https://www.ivi.int/hev-symposium-2023/